Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $4.80 Million |
|---|---|
| Enterprise Value | $5.91 Million |
| Earnings per Share | $-0.02 |
| Beta | 0.31 |
| Outstanding Shares | 205,056,565 |
| P/E Ratio | -2.05 |
|---|---|
| PEG | -1.48 |
| Price to Sales | - |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | 152.56 |
| Enterprise Value to EBIT | -1.86 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | -1.98 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse pro...